1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.

300.50
ILA
+0.10
(+0.03%)
-38.27EPS
99.65BMarket Cap
Nov 05Next Earn

Latest Stock Split

Oct 31, 1997

3:1

For every share held, investors received 3.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Oct 31, 1997
    Before—
    Split ratio3:1
    After—
    Forward

About Lineage Cell Therapeutics, Inc. stock splits

Lineage Cell Therapeutics, Inc. (TASE:LCTX) operates in the Biotechnology industry.

Lineage Cell Therapeutics, Inc. company overview

When did Lineage Cell Therapeutics, Inc. stock split?

Lineage Cell Therapeutics, Inc.'s most recent stock split was on October 31, 1997. It was a 3-for-1 forward split, so shareholders received 3 shares for every share they held.

How many times has Lineage Cell Therapeutics, Inc. stock split?

Lineage Cell Therapeutics, Inc. has split its stock once. This history records one forward split, on October 31, 1997.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lineage Cell Therapeutics, Inc.'s 3-for-1 split on October 31, 1997, every share became 3 shares.

Will Lineage Cell Therapeutics, Inc. split its stock again?

Lineage Cell Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on October 31, 1997, 28 years ago. Companies announce splits in advance, and any new TASE:LCTX split will appear on this page.